BSE filing, NSE: MERCURYLAB. Summary written from the filing by ALFA Finder's alert engine.
Mercury Laboratories Ltd: key numbers
- Share price
- ₹749.95
- Market cap
- ₹89.99 Cr
- Revenue (annual)
- ₹75.94 Cr
- Net profit (annual)
- ₹4.83 Cr
- P/E (TTM)
- 21.6×Sector 46.1×
- Promoter holding
- 73.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mercury Laboratories Ltd
All →Mercury Laboratories Management Change
Mercury Laboratories disclosed the cessation of Manager-HR Jaydeepsinh Raj, effective October 28, 2026. The employee stopped reporting for duty without prior intimation to the company.
Mercury Laboratories Other Announcement
Mercury Laboratories Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b). The report provides a standard breakdown of the company's current equity ownership structure.
Mercury Laboratories Management Change
Mr. Dilip Ramanlal Shah has ceased to be a Non-Executive Director of Mercury Laboratories Limited following the non-approval of his re-appointment at the recent AGM.
Mercury Laboratories Annual General Meeting
Mercury Laboratories Limited conducted its 45th Annual General Meeting on September 28, 2026. Shareholders considered agenda items including financial statements adoption and a ₹3.50 per share dividend.
Mercury Laboratories Management Change
Mercury Laboratories has appointed Mr. Jaydeepsinh Raj as Manager-HR, effective September 03, 2026.
Mercury Laboratories Annual Report
Mercury Laboratories Ltd has submitted its 45th Annual Report and Notice of the 45th AGM for the financial year 2025-26.
Other board meeting date announcements
All →Tatia Global Vennture Board Meeting Date
Tatia Global Vennture will hold a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 01 Oct to 07 Nov 2026.
Landmarc Leisure Corporation Board Meeting Date
Landmarc Leisure scheduled a board meeting for 06 Nov 2026 to approve Q2 FY27 results. Trading window closes from 01 Oct to 08 Nov 2026.
Augmont Enterprises Board Meeting Date
Augmont Enterprises scheduled a Board meeting for November 4, 2026, to approve unaudited Q1 and H1 financial results. Trading window remains closed until 48 hours post-declaration.
Linc Board Meeting Date
Linc Ltd announced that its Board of Directors meeting is scheduled for 5 November 2026. The agenda includes approval of unaudited financial results for Q1 and H1 FY27.
NDR Auto Components Board Meeting Date
NDR Auto Components intimated its board meeting for November 4, 2026, to approve Q1 and H1 FY27 results. No financial figures are reported.
Reliance Chemotex Industries Board Meeting Date
Reliance Chemotex notified a Board Meeting on 05 Nov 2026 to approve unaudited results for Q1 FY27. No financial figures or decisions are yet reported.